Dark

LGND
Ligand Pharmaceuticals Inc.
stock NASDAQ

At Close

May 29, 2026 3:59:55 PM EDT

232.09USD-1.095%(-2.57)153,567

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-234.66)0

After-hours

May 29, 2026 4:00:30 PM EDT

231.96USD-0.056%(-0.13)42,658

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

4.67B

CEO

John Higgins

Headquarters

San Diego, California, USA

Industry

Biotechnology

Next Earnings

Aug 6, 2026 (68d)

Last Dividend

Apr 3, 20072.500

Last Split

Nov 19, 20101for5.9999reverse

AMGN SPPI GSK BAX BMY JNJ LLY PFE MRK GTXI XLV

LGND Stats

Avg. Vol. 10 Day

194,478

Avg. Vol. 30 Day

205,291

Employees

Market Cap

4,666,761,464

Shares Out.

20,041,061

On/Off Exchange

54%/46%

6 Month Beta

1.15

1 Year Beta

1.13

2 Year Beta

1.02

3 Year Beta

1.02

52 Week Low

98.89

52 Week High

247.38

SMA50

218.21

SMA200

195.14

1 Week

+1.54%

1 Month

+1.49%

3 Month

+14.96%

6 Month

+18.22%

1 Year

+127.87%

2 Year

+177.35%

5 Year

+105.04%

Profile

ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.

LGND Stock Summary

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) stock price today is $232.09, and today's volume is 153,567. LGND is down -1.095% today. The 30 day average volume is 205,291. LGND market cap is 4.67B with 20,041,061 shares outstanding.